q2K BHP
Black History Portal
THE BHP WIRE —
HIDDEN TRUTHS
What's New!
THE JOURNEY THROUGH TIME

Explore Black History

Explore the people, places, events, achievements, struggles and stories that shaped our journey.

✊🏾

Civil Rights

Movements, leaders, victories and the continuing fight for equality.

⚙️

Black Inventors

Innovation, patents, science, technology and world-changing contributions.

🏆

Sports

Pioneers, champions, Negro Leagues, records, activism and excellence.

♟️

People

Meet the people whose lives, choices and achievements shaped the journey.

📍

Places

Black towns, communities, institutions and places where history happened.

📜

Events

Moments that changed communities, movements, institutions and the nation.

Enter a person, place, event, or topic.
MY'STORY

The MOVE Fire

This is a personal recollection on the Move fire on May 13, 1985 Philadelphia police fired thousands of rounds at the MOVE house, city officials approved dropping an explosive device on the roof, the resulting fire was allowed to burn, 11 people—including five children—died, and 61 homes were destroyed. Philadelphia City Council later called it a “brutal attack carried out by the City of Philadelphia on its own citizens” and acknowledged that no individual faced criminal consequences for the bombing. One timeline correction worth preserving for the BHP record: the major previous MOVE-police confrontation was August 8, 1978, about seven years before the bombing, not a year or two earlier. Officer James Ramp was killed, other police and firefighters were wounded, nine MOVE members were later convicted, and television cameras recorded police beating Delbert Africa during his arrest. The 1985 MOVE Commission later specifically criticized city planners for failing to adequately use lessons from that 1978 confrontation. And that actually strengthens the point you’re making: 1985 did not happen without precedent or institutional memory. There had already been a deadly confrontation with MOVE, years of conflict, negotiations and police involvement before Osage Avenue.

MORE →
BLACK FACTS
The Truths They Never Taught You...

The Violence That Helped Spark the NAACP

In August 1908, a white mob attacked Springfield, Illinois’s Black community, destroying homes and businesses and lynching two Black men. National outrage over the violence helped spur the movement that created the NAACP the following year.

MORE →
BHP gathered finds from its connected research sources. Showing the 4 strongest Black History matches.
← BACK TO RESULTS
Wikipedia

OpenEvidence

OpenEvidence
TypePrivate
IndustryArtificial intelligence
Healthcare technology
Founded2022
FoundersDaniel Nadler, Zachary Ziegler
HeadquartersMiami, Florida, United States
Area served
United States
Key peopleDaniel Nadler (Co-founder & CEO)
Zachary Ziegler (Co-founder)
Total equity$12 billion (2026)
Websitewww.openevidence.com

OpenEvidence is the name for both the product (an LLM) and the company, an American artificial intelligence company that develops a medical search engine, which is used by healthcare professionals for clinical decision-making support. The company was founded in 2022 by entrepreneur Daniel Nadler and is headquartered in Miami, Florida.[1] As of January 2026, the company is valued at $12 billion, following several funding rounds.[2]

History

[edit]

OpenEvidence was founded in 2022 by Daniel Nadler, a Harvard Ph.D. and former founder of Kensho, a financial analytics firm acquired by S&P Global in 2018.[3][4] Nadler launched the company with co-founder Zack Ziegler, a machine learning researcher from Harvard, to address the challenge physicians face in keeping up with the growing volume of medical literature.[1][5]

In 2023, OpenEvidence reported that its artificial intelligence model achieved a 90 percent score on the United States Medical Licensing Examination (USMLE).[6] During the same year, the company participated in the Mayo Clinic health-technology accelerator.[7] In 2025, the company stated that the model had reached a 100 percent score on the same examination.[5][8]

In February 2025, OpenEvidence raised $75 million in a Series A round led by Sequoia Capital, valuing the company at $1 billion.[9] In July 2025, the company secured $210 million in funding from a round led by GV (Google Ventures) and Kleiner Perkins, with participation from Coatue, Conviction, and Thrive Capital. This round valued the company at $3.5 billion.[10] In April 2025, OpenEvidence was featured in the Forbes AI 50 list.[11]

OpenEvidence has established content licensing partnerships with several medical organizations and journals, including American Medical Association, National Comprehensive Cancer Network (NCCN), American Academy of Family Physicians, American College of Emergency Physicians, New England Journal of Medicine, Journal of the American Medical Association, JAMA Network, JAMA Oncology, and JAMA Neurology.[12][5][13][14][15]

On October 20th 2025, the company announced a US$200 million Series C funding round, valuing the company at US$6 billion.[16] As of December 2025, the company reported 760,000 registered U.S. physicians and approximately 18 million clinical consultations per month.[17] In January 2026, OpenEvidence raised $250 million in a Series D funding round at a $12 billion valuation.[18][19] As of early 2026, OpenEvidence had raised approximately $700 million in total funding from investors including Google Ventures, Nvidia, Sequoia, Blackstone, Thrive Capital, Kleiner Perkins, Craft Ventures and Mayo Clinic.[20]

Partnerships

[edit]

In May 2026, OpenEvidence partnered with Cedars-Sinai to integrate its decision support platform into the hospital's electronic health record infrastructure.[21] The integration allows healthcare professionals to query medical literature using patient-specific clinical context.[22]

Product and technology

[edit]

OpenEvidence provides a Large Language Model with an artificial intelligence-based platform that analyzes and organizes peer-reviewed medical literature from clinical journals such as The New England Journal of Medicine and The Journal of the American Medical Association. According to the company, access is available at no cost to verified physicians, with revenue derived from advertising. As of July 2025, the company reported more than 430,000 registered U.S. physicians (about 40% of U.S. physicians) and use in over 8.5 million consultations per month. In the same month, OpenEvidence introduced a feature called DeepConsult, described as employing reasoning models to synthesize findings across multiple studies.[7]

In May 2026, the company introduced Voice Mode, a voice-based interface for its platform that was made available through the company's web and mobile applications.[23]

See also

[edit]

References

[edit]
  1. ^ a b Feldman, Amy. "OpenEvidence Cofounder Daniel Nadler Is Now A Billionaire". Forbes. Retrieved 2025-10-03.
  2. ^ "Medical AI startup OpenEvidence doubles valuation to $12 billion in latest round". Reuters. 2026-01-21.
  3. ^ Bertoni, Steven. "Can Kensho Bring Google Style Search To Stock Picking?". Forbes. Retrieved 2025-10-03.
  4. ^ Gara, Antoine. "Wall Street Tech Spree: With Kensho Acquisition S&P Global Makes Largest A.I. Deal In History". Forbes. Retrieved 2025-10-03.
  5. ^ a b c Landi, Heather (2025-08-15). "OpenEvidence AI scores 100% on USMLE, launches explanation model". www.fiercehealthcare.com. Retrieved 2025-10-01.
  6. ^ Roger, Olivia (July 14, 2023). "OpenEvidence's gen AI bests ChatGPT, Med-PaLM 2 on US medical licensing exam". firstwordhealthtech.com. Retrieved 2025-10-03.
  7. ^ a b Feldman, Amy. "How OpenEvidence Cofounder Daniel Nadler Became A Billionaire". Forbes ME. Retrieved 2025-10-03.
  8. ^ "Medical AI Firm Says Competitor Hacked Prompts to Steal Secrets". 2025-06-23. Archived from the original on 2025-07-24. Retrieved 2025-10-03.
  9. ^ Rooney, Kate (2025-02-19). "AI health-care startup OpenEvidence raises funding from Sequoia at $1 billion valuation". CNBC. Retrieved 2025-10-03.
  10. ^ Balasubramanian, Sai. "OpenEvidence's Meteoric Rise Is Huge For Doctors". Forbes. Retrieved 2025-10-03.
  11. ^ SHRIVASTAVA"], ["RASHI. "Forbes 2025 AI 50 List - Top Artificial Intelligence Companies Ranked". Forbes. Archived from the original on 2025-12-31. Retrieved 2026-01-12.
  12. ^ "NCCN Guidelines to Be Integrated Into OpenEvidence's Medical AI Platform". ascopost.com. 11 July 2025. Retrieved 2026-02-24.
  13. ^ Landi, Heather (2026-01-21). "OpenEvidence clinches $250M, doubles valuation to $12B". www.fiercehealthcare.com. Retrieved 2026-02-22.
  14. ^ Haupt, Angela. "TIME100 Health: Daniel Nadler". TIME. Archived from the original on 2025-06-16. Retrieved 2025-10-03.
  15. ^ "How What is OpenEvidence? AI Medical Search for Physicians". aiforsocialgood.ca. 2025-10-15. Retrieved 2025-10-15.
  16. ^ "OpenEvidence Raises $200 Million for a ChatGPT for Medicine". The New York Times. 2025-10-20. Retrieved 2025-11-11.
  17. ^ Landi, Heather (2026-01-21). "OpenEvidence clinches $250M, doubles valuation to $12B". www.fiercehealthcare.com. Retrieved 2026-02-24.
  18. ^ "Medical AI startup OpenEvidence doubles valuation to $12 billion in latest round". EnterpriseAI (from The Economic Times). 2026-01-22.
  19. ^ Kate Rooney (January 21, 2026). "OpenEvidence, the 'ChatGPT for doctors,' doubles valuation to $12 billion". CNBC. Retrieved January 26, 2026.
  20. ^ Shrivastava, Rashi. "AI Founder Daniel Nadler Is Twice As Rich After OpenEvidence Hits $12 Billion Valuation". Forbes. Archived from the original on 2026-02-17. Retrieved 2026-02-22.
  21. ^ Landi, Heather (2026-05-21). "OpenEvidence CEO says AI enterprise model in the works". www.fiercehealthcare.com. Retrieved 2026-08-22.
  22. ^ Martinez, Cara (May 20, 2026). "Cedars-Sinai and OpenEvidence Partner on AI Health Solution". cedars-sinai.org. Retrieved 2026-08-22.
  23. ^ "OpenEvidence Brings Hands-Free Medical AI to 860,000 Clinicians". PYMNTS.com. 2026-05-21. Retrieved 2026-08-22.
[edit]

Source: Wikipedia. Article content is retrieved live through the MediaWiki API.

Wikipedia

OpenEvidence

OpenEvidence is the name for both the product (an LLM) and the company, an American artificial intelligence company that develops a medical search engine, which is used by healthcare professionals for clinical decision-making support. The company was founded in 2022 by entrepreneur Daniel Nadler and is headquartered in Miami, Florida. As of January 2026, the company is valued at $12 billion, following several funding rounds.

MORE →
No preview image
Wikipedia

Kleiner Perkins

Kleiner Perkins Caufield & Byers, LLC, commonly known as Kleiner Perkins or KP, is an American venture capital firm which specializes in investing in early stage and growth companies. Since its founding in 1972, the firm has supported America Online, Amazon.com, Tandem Computers, Compaq, Electronic Arts, JD.com, Square, Genentech, Google, Netscape, Sun Microsystems, Nest, Palo Alto Networks, Synack, Snap, AppDynamics, Twitter, Applied Intuition, Anthropic, Waymo, Glean Technologies, OpenEvidence, Rippling, Harvey & Together AI. By 2024, it had raised 21 venture capital funds and six growth funds. In 2026, the firm announce its twenty-second venture fund, KP22, a $1 billion fund to back early-stage companies, and $2.5 billion in growth funds to back businesses. Kleiner Perkins is headquartered in Menlo Park in Silicon Valley, with offices in San Francisco and Shanghai, China.

MORE →
No preview image
Wikipedia

Daniel Nadler

Daniel J. Nadler (born 1983) is a Canadian-born billionaire entrepreneur and poet. He is the founder and CEO of OpenEvidence, an artificial intelligence company that develops a medical search and clinical decision-support platform for physicians. He previously founded Kensho Technologies, which was acquired by S&P Global in 2018. Nadler's debut poetry collection, Lacunae: 100 Imagined Ancient Love Poems (2016), was described by The Washington Post as a "striking debut". He was included in the Time 100 Health list of the 100 most influential individuals in global health. As of 2026, Forbes estimated his net worth was at US$7.6 billion.

MORE →
Wikipedia

AdventHealth

Adventist Health System Sunbelt Healthcare Corporation (doing business as AdventHealth, and formerly as Adventist Health System initialed as AHS) is an American hospital network. It is headquartered in Altamonte Springs, Florida. It operates healthcare facilities across multiple states. It is the largest Protestant nonprofit organization in the country and is affiliated with the Seventh-day Adventist Church. AdventHealth is a founding member of Coalition for Health AI (CHAI) and the Trustworthy and Responsible AI Network (TRAIN). The hospital network is the Official Health Care Provider for Florida Citrus Sports, Legoland Florida Resort, Orlando Magic, Orlando Solar Bears, Orlando Squeeze and Orlando Valkyries; the Official Health Care Partner for Daytona International Speedway; the Official Health and Wellness Partner for the Tampa Bay Lightning; the Official Medical Provider for runDisney and also Osceola Magic . Other partners of AdventHealth are Dr. Phillips Center for the Performing Arts, Track Shack, USTA National Campus and Walt Disney World. In 2021, AdventHealth was the second-largest hospital network in Florida. In February 2026, it was listed as the eleventh-largest hospital system nationwide. In July 2026, it was listed as the second largest employer in central Florida. As of August 2026, AdventHealth operated 57 hospitals across nine states, spanning 55 campuses. Becker's Hospital Review and Healthcare Dive count only 55 hospitals as they exclude AdventHealth for Children and AdventHealth for Women. On March 19, 2015, Adventist Health System settled a lawsuit that accused it of violating the False Claims Act for $5.4 million, for unsupervised radiation precedures. On September 21, the hospital network settled multiple lawsuits for a total of $118.7 million, that accused it of violating the Stark Law and False Claims Act. It was the largest settlement ever paid by a hospital network for violating the Stark Law. On February 19, 2016, the hospital network settled a lawsuit that accused it of violating the False Claims Act for $2.09 million, after one of its hospitals used leftover chemotherapy drugs. On January 2, 2019, the majority of the medical facilities were rebranded to AdventHealth. The rebranding excluded facilities in Colorado, Illinois, and Texas operated through joint ventures. In March 2022, the hospital network became the first to receive the Emerald Award from the Leapfrog Group, recognizing achievements in healthcare quality and safety. In April, AdventHealth and Ascension dissolved their joint venture AMITA Health. On September 1, the organization announced a rapid diagnostic test to detect Naegleria fowleri, commonly referred to as brain-eating amoebas. In August 2023, AdventHealth and CommonSpirit Health dissolved their joint venture Centura Health. In November 2024, AdventHealth ranked first on Gartner's Healthcare Supply Chain Top 25 list, its first time at the top. In April 2025, David Banks became president and CEO of AdventHealth, replacing Terry Shaw who retired after 40 years with the hospital network.

MORE →
TOPIC OF THE DAY

Greenwood / Black Wall Street

Before the 1921 destruction of Tulsa’s Greenwood District, Black residents had created a remarkable center of business and community life. The district included stores, professional offices, entertainment venues and homes owned by Black citizens. Understanding Greenwood means learning what was built—not only what was burned.

MORE →
TRIVIA QUESTION OF THE DAY

Which Supreme Court case ruled state-sponsored public-school segregation unconstitutional?

Brown v. Board of Education in 1954.